New drug solrikitug put to the test in healthy volunteers
NCT ID NCT06868082
First seen Jan 17, 2026 · Last updated May 06, 2026 · Updated 13 times
Summary
This early-stage study tested the safety and tolerability of a new drug called solrikitug in 32 healthy adults, both Japanese and non-Japanese. Participants received the drug under the skin in one of two forms. The goal was to check for side effects and measure how the drug moves through the body, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Brisbane, Queensland, Australia
Conditions
Explore the condition pages connected to this study.